Outcomes of Acute Myeloid Leukemia Patients
NCT04392310 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-05-18
Summary
1. To assess overall survival of AML patient.
2. To measure rate of disease free survival.
3. rate of non relapse mortality.
4. rate of complete remission .
5. percentage of refractory disease.
6. percentage of relapsed disease.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2020-10-01
- Completion
- 2020-11-01
More Related Trials
-
Oral Arsenic Trioxide for NPM1-mutated AML
NCT04689815 ·Status: UNKNOWN ·Phase: PHASE2
-
Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition
NCT03284593 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
NCT04777916 ·Status: RECRUITING
-
Relation of C-reactive Protein/ Albumin Ratio and Coagulation Profile in Acute Myeloid Leukemia Patients
NCT06714071 ·Status: NOT_YET_RECRUITING
-
A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy
NCT02677922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia
NCT01743859 ·Status: COMPLETED ·Phase: PHASE2
-
Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia
NCT06225128 ·Status: RECRUITING
-
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 ·Status: RECRUITING
-
Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital
NCT05558943 ·Status: NOT_YET_RECRUITING
-
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
NCT05224661 ·Status: ACTIVE_NOT_RECRUITING
-
Transfusion in Adult Acute Myeloid Leukemia
NCT02899767 ·Status: COMPLETED
-
Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia
NCT02844257 ·Status: COMPLETED
-
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
NCT06379360 ·Status: RECRUITING ·Phase: PHASE2
-
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
NCT00186381 ·Status: COMPLETED ·Phase: PHASE2
-
D-index as a Predictor of Complication of Treatment of Patients With Acute Myeloid Leukemia
NCT06188182 ·Status: NOT_YET_RECRUITING
-
FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.
NCT05383014 ·Status: UNKNOWN
-
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
NCT05772559 ·Status: RECRUITING
-
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
NCT04215822 ·Status: UNKNOWN
-
Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments
NCT06764459 ·Status: RECRUITING
-
Immunophenotyping and Xist Gene in AML
NCT04288739 ·Status: UNKNOWN
-
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients
NCT04259372 ·Status: COMPLETED
-
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia
NCT05042531 ·Status: UNKNOWN ·Phase: NA
-
Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)
NCT02662920 ·Status: COMPLETED
-
Quality of Life Model for Older Patients With AML
NCT04380441 ·Status: ACTIVE_NOT_RECRUITING
-
Chronic Myelod Leukemia Registry at Asan Medical Center
NCT01761695 ·Status: TERMINATED